DNA Repair and Redox Activities and Inhibitors of Apurinic/Apyrimidinic Endonuclease 1/Redox Effector Factor 1 (APE1/Ref-1): A Comparative Analysis and Their Scope and Limitations toward Anticancer Drug Development

被引:34
作者
Kaur, Gagandeep [1 ]
Cholia, Ravi P. [2 ]
Mantha, Anil K. [2 ]
Kumar, Raj [1 ]
机构
[1] Cent Univ Punjab, Lab Drug Design & Synth, Ctr Chem & Pharmaceut Sci, Sch Basic & Appl Sci, Bathinda 151001, Punjab, India
[2] Cent Univ Punjab, Ctr Biosci, Sch Basic & Appl Sci, Bathinda 151001, Punjab, India
关键词
BASE-EXCISION-REPAIR; NF-KAPPA-B; SMALL-MOLECULE INHIBITOR; STRAND BREAK REPAIR; SIGNALING PROTEIN APE1/REF-1; CRITICAL LYSINE RESIDUES; RADIOTHERAPY IN-VITRO; CANCER CELL-GROWTH; SUBCELLULAR-LOCALIZATION; MAJOR HUMAN;
D O I
10.1021/jm500865u
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The apurinic/apyrimidinic endonuclease 1/redox effector factor 1 (APE1/Ref-1) is a multifunctional enzyme involved in DNA repair and activation of transcription factors through its redox function. The evolutionarily conserved C- and N-termini are involved in these functions independently. It is also reported that the activity of APE1/Ref-1 abruptly increases several-fold in various human cancers. The control over the outcomes of these two functions is emerging as a new strategy to combine enhanced DNA damage and chemotherapy in order to tackle the major hurdle of increased cancer cell growth and proliferation. Studies have targeted these two domains individually for the design and development of inhibitors for APE1/Ref-1. Here, we have made, for the first time, an attempt at a comparative analysis of APE1/Ref-1 inhibitors that target both DNA repair and redox activities simultaneously. We further discuss their scope and limitations with respect to the development of potential anticancer agents.
引用
收藏
页码:10241 / 10256
页数:16
相关论文
共 163 条
[1]  
A S., 2013, New Research Directions in DNA Repair, DOI DOI 10.5772/53952
[2]  
Abbotts R.M., 2011, DNA REPAIR HUMAN HLT, P495
[3]   Human AP endonuclease 1 (APE1): From mechanistic insights to druggable target in cancer [J].
Abbotts, Rachel ;
Madhusudan, Srinivasan .
CANCER TREATMENT REVIEWS, 2010, 36 (05) :425-435
[4]  
Agaçhan B, 2009, ANTICANCER RES, V29, P2417
[5]   Human apurinic/apyrimidinic endonuclease (APE1) is a prognostic factor in ovarian, gastro-oesophageal and pancreatico-biliary cancers [J].
Al-Attar, A. ;
Gossage, L. ;
Fareed, K. R. ;
Shehata, M. ;
Mohammed, M. ;
Zaitoun, A. M. ;
Soomro, I. ;
Lobo, D. N. ;
Abbotts, R. ;
Chan, S. ;
Madhusudan, S. .
BRITISH JOURNAL OF CANCER, 2010, 102 (04) :704-709
[6]   A unified view of base excision repair: Lesion-dependent protein complexes regulated by post-translational modification [J].
Almeida, Karen H. ;
Sobol, Robert W. .
DNA REPAIR, 2007, 6 (06) :695-711
[7]   A new APE1/Ref-1-dependent pathway leading to reduction of NF-κB and AP-1, and activation of their DNA-binding activity [J].
Ando, Kozue ;
Hirao, Satoshi ;
Kabe, Yasuaki ;
Ogura, Yuji ;
Sato, Iwao ;
Yamaguchi, Yuki ;
Wada, Tadashi ;
Handa, Hiroshi .
NUCLEIC ACIDS RESEARCH, 2008, 36 (13) :4327-4336
[8]   Novel Small-Molecule Inhibitor of Apurinic/Apyrimidinic Endonuclease 1 Blocks Proliferation and Reduces Viability of Glioblastoma Cells [J].
Bapat, Aditi ;
Glass, LaTeca S. ;
Luo, Meihua ;
Fishel, Melissa L. ;
Long, Eric C. ;
Georgiadis, Millie M. ;
Kelley, Mark R. .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2010, 334 (03) :988-998
[9]  
Bapat A, 2009, ANTIOXID REDOX SIGN, V11, P651, DOI [10.1089/ars.2008.2218, 10.1089/ARS.2008.2218]
[10]   Identification of Apurinic/apyrimidinic endonuclease 1 (APE1) as the endoribonuclease that cleaves c-myc mRNA [J].
Barnes, Tavish ;
Kim, Wan-Cheol ;
Mantha, Anil K. ;
Kim, Sang-Eun ;
Izumi, Tadahide ;
Mitra, Sankar ;
Lee, Chow H. .
NUCLEIC ACIDS RESEARCH, 2009, 37 (12) :3946-3958